245 related articles for article (PubMed ID: 12958312)
41. TNF receptor-associated factor-3 signaling mediates activation of p38 and Jun N-terminal kinase, cytokine secretion, and Ig production following ligation of CD40 on human B cells.
Grammer AC; Swantek JL; McFarland RD; Miura Y; Geppert T; Lipsky PE
J Immunol; 1998 Aug; 161(3):1183-93. PubMed ID: 9686578
[TBL] [Abstract][Full Text] [Related]
42. HOIL-1L interacting protein (HOIP) is essential for CD40 signaling.
Hostager BS; Kashiwada M; Colgan JD; Rothman PB
PLoS One; 2011; 6(8):e23061. PubMed ID: 21829693
[TBL] [Abstract][Full Text] [Related]
43. The binding site for TRAF2 and TRAF3 but not for TRAF6 is essential for CD40-mediated immunoglobulin class switching.
Jabara H; Laouini D; Tsitsikov E; Mizoguchi E; Bhan A; Castigli E; Dedeoglu F; Pivniouk V; Brodeur S; Geha R
Immunity; 2002 Sep; 17(3):265-76. PubMed ID: 12354380
[TBL] [Abstract][Full Text] [Related]
44. Multiple carboxyl-terminal regions of the EBV oncoprotein, latent membrane protein 1, cooperatively regulate signaling to B lymphocytes via TNF receptor-associated factor (TRAF)-dependent and TRAF-independent mechanisms.
Busch LK; Bishop GA
J Immunol; 2001 Nov; 167(10):5805-13. PubMed ID: 11698454
[TBL] [Abstract][Full Text] [Related]
45. TRAF2 Ser-11 Phosphorylation Promotes Cytosolic Translocation of the CD40 Complex To Regulate Downstream Signaling Pathways.
Workman LM; Zhang L; Fan Y; Zhang W; Habelhah H
Mol Cell Biol; 2020 Apr; 40(9):. PubMed ID: 32041822
[TBL] [Abstract][Full Text] [Related]
46. Phosphorylation of TRAF2 inhibits binding to the CD40 cytoplasmic domain.
Chaudhuri A; Orme S; Vo T; Wang W; Cherayil BJ
Biochem Biophys Res Commun; 1999 Mar; 256(3):620-5. PubMed ID: 10080948
[TBL] [Abstract][Full Text] [Related]
47. Rapid CD40-mediated rescue from CD95-induced apoptosis requires TNFR-associated factor-6 and PI3K.
Benson RJ; Hostager BS; Bishop GA
Eur J Immunol; 2006 Sep; 36(9):2535-43. PubMed ID: 16897814
[TBL] [Abstract][Full Text] [Related]
48. An atypical tumor necrosis factor (TNF) receptor-associated factor-binding motif of B cell-activating factor belonging to the TNF family (BAFF) receptor mediates induction of the noncanonical NF-kappaB signaling pathway.
Morrison MD; Reiley W; Zhang M; Sun SC
J Biol Chem; 2005 Mar; 280(11):10018-24. PubMed ID: 15644327
[TBL] [Abstract][Full Text] [Related]
49. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2.
Eliopoulos AG; Blake SM; Floettmann JE; Rowe M; Young LS
J Virol; 1999 Feb; 73(2):1023-35. PubMed ID: 9882303
[TBL] [Abstract][Full Text] [Related]
50. TRAF2 deficiency results in hyperactivity of certain TNFR1 signals and impairment of CD40-mediated responses.
Nguyen LT; Duncan GS; Mirtsos C; Ng M; Speiser DE; Shahinian A; Marino MW; Mak TW; Ohashi PS; Yeh WC
Immunity; 1999 Sep; 11(3):379-89. PubMed ID: 10514016
[TBL] [Abstract][Full Text] [Related]
51. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
Eliopoulos AG; Stack M; Dawson CW; Kaye KM; Hodgkin L; Sihota S; Rowe M; Young LS
Oncogene; 1997 Jun; 14(24):2899-916. PubMed ID: 9205097
[TBL] [Abstract][Full Text] [Related]
52. CD40-mediated activation of Ig-Cgamma1- and Ig-cepsilon germ-line promoters involves multiple TRAF family proteins.
Leo E; Zapata JM; Reed JC
Eur J Immunol; 1999 Dec; 29(12):3908-13. PubMed ID: 10601998
[TBL] [Abstract][Full Text] [Related]
53. TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival.
Lee SY; Reichlin A; Santana A; Sokol KA; Nussenzweig MC; Choi Y
Immunity; 1997 Nov; 7(5):703-13. PubMed ID: 9390693
[TBL] [Abstract][Full Text] [Related]
54. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling.
Lomaga MA; Yeh WC; Sarosi I; Duncan GS; Furlonger C; Ho A; Morony S; Capparelli C; Van G; Kaufman S; van der Heiden A; Itie A; Wakeham A; Khoo W; Sasaki T; Cao Z; Penninger JM; Paige CJ; Lacey DL; Dunstan CR; Boyle WJ; Goeddel DV; Mak TW
Genes Dev; 1999 Apr; 13(8):1015-24. PubMed ID: 10215628
[TBL] [Abstract][Full Text] [Related]
55. TRAF2 plays a key, nonredundant role in LIGHT-lymphotoxin beta receptor signaling.
Kim YS; Nedospasov SA; Liu ZG
Mol Cell Biol; 2005 Mar; 25(6):2130-7. PubMed ID: 15743811
[TBL] [Abstract][Full Text] [Related]
56. AIP1/DAB2IP, a novel member of the Ras-GAP family, transduces TRAF2-induced ASK1-JNK activation.
Zhang H; Zhang R; Luo Y; D'Alessio A; Pober JS; Min W
J Biol Chem; 2004 Oct; 279(43):44955-65. PubMed ID: 15310755
[TBL] [Abstract][Full Text] [Related]
57. Blockade of CD40-TRAF2,3 or CD40-TRAF6 is sufficient to inhibit pro-inflammatory responses in non-haematopoietic cells.
Portillo JA; Greene JA; Schwartz I; Subauste MC; Subauste CS
Immunology; 2015 Jan; 144(1):21-33. PubMed ID: 25051892
[TBL] [Abstract][Full Text] [Related]
58. TRAF interactions with raft-like buoyant complexes, better than TRAF rates of degradation, differentiate signaling by CD40 and EBV latent membrane protein 1.
Ardila-Osorio H; Pioche-Durieu C; Puvion-Dutilleul F; Clausse B; Wiels J; Miller W; Raab-Traub N; Busson P
Int J Cancer; 2005 Jan; 113(2):267-75. PubMed ID: 15386359
[TBL] [Abstract][Full Text] [Related]
59. TRAF1 is a critical regulator of JNK signaling by the TRAF-binding domain of the Epstein-Barr virus-encoded latent infection membrane protein 1 but not CD40.
Eliopoulos AG; Waites ER; Blake SM; Davies C; Murray P; Young LS
J Virol; 2003 Jan; 77(2):1316-28. PubMed ID: 12502848
[TBL] [Abstract][Full Text] [Related]
60. NF-kappaB activation in CD27 signaling: involvement of TNF receptor-associated factors in its signaling and identification of functional region of CD27.
Yamamoto H; Kishimoto T; Minamoto S
J Immunol; 1998 Nov; 161(9):4753-9. PubMed ID: 9794406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
